StonvexLoading…
StonvexStonvexStonvexCore line items from NTR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $26.89B | $25.97B | $29.06B | $37.88B |
Operating Income | $3.74B | $1.86B | $2.75B | $10.81B |
Net Income | $2.30B | $700.00M | $1.28B | $7.69B |
EPS (Diluted) | $4.66 | $1.36 | $2.53 | $14.18 |
Total Assets | $52.30B | $51.84B | $52.75B | $54.59B |
Total Liabilities | $26.94B | $27.40B | $27.55B | $28.72B |
Cash & Equivalents | $701.00M | $853.00M | $941.00M | $901.00M |
Free Cash Flow OCF − CapEx | $2.13B | $1.51B | $2.65B | $5.86B |
Shares Outstanding | Not available | 491.03M | 494.55M | 507.25M |